Completed OBSERVATIONAL NCT02227758

Peripheral Nerve Stimulation Registry for Intractable Migraine Headache (Relief)

Sponsor: Abbott Medical Devices

Updated 12 times since 2017 Last updated: Jan 31, 2019 Started: Sep 30, 2012 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Intractable Chronic Migraine and is currently completed. Abbott Medical Devices leads this study, which shows 12 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed

▶ Show 7 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed
Mar 2019 — Jan 2021 [monthly]

Completed
Feb 2019 — Mar 2019 [monthly]

Completed
Jan 2019 — Feb 2019 [monthly]

Completed
Jun 2018 — Jan 2019 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices

Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Berlin, Germany , Delmenhorst, Germany , Düsseldorf, Germany , Essen, Germany , Kiel, Germany , Königstein, Germany , Leeds, United Kingdom , Liège, Belgium , London, United Kingdom , Luxembourg, Luxembourg and 5 more locations